| Date |
Report No. |
Title |
| Date Dec. 9, 2011 |
Report No. GAO-12-53 |
Title
GAO
December 2011 United States Government Accountability Office Report to Congressional Committees ADULT DRUG COURTS Studies Show Courts Reduce Recidivism, but DOJ Could Enhance Future Performance Measure Revision Efforts GAO-12-53 December 2011 ADULT DRUG COURTS
Highlights of GAO-12-53, a report to congressional committees Studies Show Courts Reduce Recidivism, but DOJ Could Enhance Future Perfo... |
| Date Dec. 1, 2011 |
Report No. GAO-12-270T |
Title
GAO
For Release on Delivery Expected at 10:30 a.m. EST Thursday, December 1, 2011 United States Government Accountability Office Testimony
Before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate FOSTER CHILDREN HHS Guidance Could Help States Improve Oversight ... |
| Date Oct. 24, 2011 |
Report No. GAO-12-46 |
Title
United States Government Accountability Office GAO
October 2011 Report to Congressional Requesters FOOD AND DRUG ADMINISTRATION Better Coordination Could Enhance Efforts to Address Economic Adulteration and Protect the Public Health GAO-12-46 October 2011 FOOD AND DRUG ADMINISTRATION
Better Coordination Could Enhance Efforts to Address Economic Adulteration and Protect the Public Health Highlights... |
| Date Oct. 4, 2011 |
Report No. GAO-12-104T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:30 a.m. EDT Tuesday, October 4, 2011 Testimony
Before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate MEDICARE PART D Instances of Questionable Access to Prescription Dr... |
| Date Sept. 23, 2011 |
Report No. GAO-11-836 |
Title
United States Government Accountability Office GAO
September 2011 Report to Congressional Committees DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement GAO-11-836 September 2011 DRUG PRICING
Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
Highlights of GAO-11-836, a report to congression... |
| Date Sept. 14, 2011 |
Report No. GAO-11-936T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Wednesday, September 14, 2011 Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate DRUG SAFETY FDA Faces Challenges Overseeing the Foreign Drug Manufacturing Supply Chain
Statement of Marcia Crosse Director, Health Care GAO-11-936T September 14, 2011 DRUG SAFETY
FD... |
| Date Sept. 6, 2011 |
Report No. GAO-11-699 |
Title
United States Government Accountability Office GAO
September 2011 Report to Congressional Requesters MEDICARE PART D Instances of Questionable Access to Prescription Drugs GAO-11-699 September 2011 MEDICARE PART D
Instances of Questionable Access to Prescription Drugs
Highlights of GAO-11-699, a report to congressional requesters Why GAO Did This Study
In 2009, GAO reported on doctor shopping in M... |
| Date June 1, 2011 |
Report No. GAO-11-406 |
Title
United States Government Accountability Office GAO
June 2011 Report to the Committee on Agriculture, House of Representatives ANTIBIOTIC RESISTANCE Data Gaps Will Remain Despite HHS Taking Steps to Improve Monitoring GAO-11-406 June 2011 ANTIBIOTIC RESISTANCE
Accountability • Integrity • Reliability Data Gaps Will Remain Despite HHS Taking Steps to Improve Monitoring
Highlights of GAO-11-406, ... |
| Date May 26, 2011 |
Report No. GAO-11-564R |
Title
United States Government Accountability Office Washington, DC 20548 May 26, 2011 The Honorable Claire McCaskill Chairman Subcommittee on Contracting Oversight Committee on Homeland Security and Governmental Affairs United States Senate Dear Madam Chairman: Subject: Department of State’s Counternarcotics Performance Management System Our recent reviews of U.S counternarcotics programs in Mexico a... |
| Date April 14, 2011 |
Report No. GAO-11-286 |
Title
United States Government Accountability Office GAO
April 2011 Report to Congressional Requesters SEAFOOD SAFETY FDA Needs to Improve Oversight of Imported Seafood and Better Leverage Limited Resources GAO-11-286 April 2011 SEAFOOD SAFETY
Accountability • Integrity • Reliability FDA Needs to Improve Oversight of Imported Seafood and Better Leverage Limited Resources
Highlights of GAO-11-286, a ... |
| Date March 24, 2011 |
Report No. GAO-11-187 |
Title
United States Government Accountability Office GAO
March 2011 Report to Congressional Requesters CRIMINAL ALIEN STATISTICS Information on Incarcerations, Arrests, and Costs GAO-11-187 March 2011 CRIMINAL ALIEN STATISTICS
Accountability • Integrity • Reliability Information on Incarcerations, Arrests, and Costs
Highlights of GAO-11-187, a report to congressional requesters Why GAO Did This Stud... |
| Date March 23, 2011 |
Report No. GAO-11-365 |
Title
United States Government Accountability Office GAO
March 2011 Report to Congressional Committees END-STAGE RENAL DISEASE CMS Should Assess Adequacy of Payment When Certain Oral Drugs Are Included and Ensure Availability of Quality Monitoring Data GAO-11-365 March 2011 END-STAGE RENAL DISEASE
Accountability • Integrity • Reliability CMS Should Assess Adequacy of Payment When Certain Oral Drugs ... |
| Date Dec. 15, 2010 |
Report No. GAO-11-141R |
Title
United States Government Accountability Office Washington, DC 20548 December 15, 2010 The Honorable Henry A. Waxman Chairman Committee on Energy and Commerce House of Representatives Subject: Medicaid Outpatient Prescription Drugs: Estimated Changes to Federal Upper Limits Using the Formula under the Patient Protection and Affordable Care Act Dear Mr. Chairman: Spending on prescription drugs in Me... |
| Date Sept. 30, 2010 |
Report No. GAO-10-961 |
Title
United States Government Accountability Office GAO
September 2010 Report to the Committee on Oversight and Government Reform, House of Representatives DRUG SAFETY FDA Has Conducted More Foreign Inspections and Begun to Improve Its Information on Foreign Establishments, but More Progress Is Needed GAO-10-961 September 2010 DRUG SAFETY
Accountability • Integrity • Reliability FDA Has Conducted M... |
| Date July 30, 2010 |
Report No. GAO-10-798 |
Title
United States Government Accountability Office GAO
July 2010 Report to Congressional Requesters NEW DRUG APPROVAL FDA’s Consideration of Evidence from Certain Clinical Trials GAO-10-798 July 2010 NEW DRUG APPROVAL Highlights
Highlights of GAO-10-798, a report to congressional requesters Accountability Integrity Reliability FDA’s Consideration of Evidence from Certain Clinical Trials Why GAO Di... |
| Date July 21, 2010 |
Report No. GAO-10-921T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Wednesday, July 21, 2010 Testimony Before the Subcommittee on Domestic Policy, Committee on Oversight and Government Reform, House of Representatives DRUG CONTROL International Programs Face Significant Challenges Reducing the Supply of Illegal Drugs but Support Broad U.S. Foreign Policy Objective... |
| Date July 21, 2010 |
Report No. GAO-10-837 |
Title
United States Government Accountability Office GAO
July 2010 Report to Congressional Requesters MÉRIDA INITIATIVE The United States Has Provided Counternarcotics and Anticrime Support but Needs Better Performance Measures GAO-10-837 July 2010 MÉRIDA INITIATIVE Highlights
Highlights of GAO-10-837, a report to congressional requesters Accountability Integrity Reliability The United States Has Prov... |
| Date July 21, 2010 |
Report No. GAO-10-913T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:30 p.m. EDT Wednesday, July 21, 2010 Testimony Before the Subcommittee on the Western Hemisphere, Committee on Foreign Affairs, House of Representatives MÉRIDA INITIATIVE The United States Needs Better Performance Measures for Its Counternarcotics and Anticrime Support Efforts
Statement of Jess T. Ford, Direc... |
| Date July 15, 2010 |
Report No. GAO-10-932T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Thursday, July 15, 2010 Testimony Before the Subcommittee on State, Foreign Operations, and Related Programs, Committee on Appropriations AFGHANISTAN DEVELOPMENT USAID Continues to Face Challenges in Managing and Overseeing U.S. Development Assistance Programs
Statement of Charles Michael Johnson ... |
| Date July 14, 2010 |
Report No. GAO-10-368 |
Title
United States Government Accountability Office GAO
July 2010 Report to Congressional Addressees AFGHANISTAN DEVELOPMENT Enhancements to Performance Management and Evaluation Efforts Could Improve USAID’s Agricultural Programs GAO-10-368 a July 2010 AFGHANISTAN DEVELOPMENT Highlights
Highlights of GAO-10-368, a report to congressional addressees Accountability Integrity Reliability Enhancements t... |
| Date July 14, 2010 |
Report No. GAO-10-756SP |
Title
Afghanistan Development: Poverty and Major Crop Production (GAO-10-756SP), an E-supplement to GAO-10-368 Read the Full Report: Afghanistan Development: Enhancements to Performance Management and Evaluation Efforts Could Improve USAID’s Agricultural Programs (GAO-10-368) Table of Contents Background Information ......................................................................................... |
| Date April 19, 2010 |
Report No. GAO-10-652CG |
Title
Leadership Challenges Given Today’s Fiscal Realities
Excellence in Government Conference Washington, D.C. April 19, 2010 Gene L. Dodaro Acting Comptroller General GAO-10-652-CG • Long-Term Fiscal Challenges • American Recovery and Reinvestment Act Implementation • Emergency Economic Stabilization Act Experience • Examples of the Need for Transformation GAO-10-652-CG 2 Long-Term Fiscal Ch... |
| Date March 31, 2010 |
Report No. GAO-10-295 |
Title
United States Government Accountability Office GAO
March 2010 Report to Congressional Requesters END-STAGE RENAL DISEASE CMS Should Monitor Access to and Quality of Dialysis Care Promptly after Implementation of New Bundled Payment System GAO-10-295 March 2010 END-STAGE RENAL DISEASE Highlights
Highlights of GAO-10-295, a report to congressional requesters Accountability Integrity Reliability CMS ... |
| Date Nov. 9, 2009 |
Report No. GAO-10-68 |
Title
United States Government Accountability Office GAO
November 2009 Report to the Ranking Member, Committee on Finance, U.S. Senate DRUG SAFETY FDA Has Begun Efforts to Enhance Postmarket Safety, but Additional Actions Are Needed GAO-10-68 November 2009 DRUG SAFETY Highlights
Highlights of GAO-10-68, a report to the Ranking Member, Committee on Finance, U.S. Senate Accountability Integrity Reliabilit... |
| Date Sept. 30, 2009 |
Report No. GAO-09-1004T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 3:00 p.m. EDT Wednesday, September 30, 2009 Testimony before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate MEDICAID Fraud and Abuse Related to Controlled Substances Ident... |
| Date Sept. 9, 2009 |
Report No. GAO-09-957 |
Title
United States Government Accountability Office GAO
September 2009 Report to Congressional Requesters MEDICAID Fraud and Abuse Related to Controlled Substances Identified in Selected States GAO-09-957 September 2009 MEDICAID Highlights
Highlights of GAO-09-957, a report to congressional requesters Accountability Integrity Reliability Fraud and Abuse Related to Controlled Substances Identified in Se... |
| Date July 20, 2009 |
Report No. GAO-09-806 |
Title
United States Government Accountability Office GAO
July 2009 Report to the Ranking Member, Committee on Foreign Relations, U.S. Senate DRUG CONTROL U.S. Counternarcotics Cooperation with Venezuela Has Declined GAO-09-806 July 2009 DRUG CONTROL Highlights
Highlights of GAO-09-806, a report to the Ranking Member, Committee on Foreign Relations, U.S. Senate Accountability Integrity Reliability U.S. C... |
| Date March 26, 2009 |
Report No. GAO-09-341 |
Title
United States Government Accountability Office GAO
March 2009 Report to Congressional Requesters METHADONEASSOCIATED OVERDOSE DEATHS Factors Contributing to Increased Deaths and Efforts to Prevent Them GAO-09-341 March 2009 Highlights
Highlights of GAO-09-341, a report to congressional requesters Accountability Integrity Reliability METHADONE-ASSOCIATED OVERDOSE DEATHS
Factors Contributing to Incr... |
| Date March 20, 2009 |
Report No. GAO-09-63 |
Title
United States Government Accountability Office GAO
March 2009 Report to the Co-Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Better Coordination with the Department of Homeland Security and an Updated Accountability Framework Can Further Enhance DEA’s Efforts to Meet Post-9/11 Responsibilities GAO-09-63 March 2009 DRUG CONTROL Highlights
Highlights of GAO-09-63, a... |
| Date March 12, 2009 |
Report No. GAO-09-339R |
Title
United States Government Accountability Office Washington, DC 20548 March 12, 2009 The Honorable Richard J. Durbin Chairman The Honorable Susan M. Collins Ranking Member Subcommittee on Financial Services and General Government Committee on Appropriations United States Senate The Honorable José E. Serrano Chairman The Honorable Jo Ann Emerson Ranking Member Subcommittee on Financial Services and ... |
| Date Feb. 20, 2009 |
Report No. GAO-09-245 |
Title
United States Government Accountability Office GAO
February 2009 Report to Congressional Requesters NONPRESCRIPTION DRUGS Considerations Regarding a Behind-the-Counter Drug Class GAO-09-245 February 2009 NONPRESCRIPTION DRUGS Highlights
Highlights of GAO-09-245, a report to congressional requesters Accountability Integrity Reliability Considerations Regarding a Behind-the-Counter Drug Class Why GA... |
| Date Oct. 6, 2008 |
Report No. GAO-09-71 |
Title
United States Government Accountability Office GAO
October 2008 Report to the Honorable Joseph R. Biden, Jr., Chairman, Committee on Foreign Relations, U.S. Senate PLAN COLOMBIA Drug Reduction Goals Were Not Fully Met, but Security Has Improved; U.S. Agencies Need More Detailed Plans for Reducing Assistance GAO-09-71 October 2008 PLAN COLOMBIA Highlights
Highlights of GAO-09-71, a report to the Ho... |
| Date Sept. 30, 2008 |
Report No. GAO-08-671 |
Title
United States Government Accountability Office GAO
September 2008 Report to Congressional Requesters INFLUENZA PANDEMIC HHS Needs to Continue Its Actions and Finalize Guidance for Pharmaceutical Interventions GAO-08-671 September 2008 INFLUENZA PANDEMIC Highlights
Highlights of GAO-08-671, a report to congressional requesters Accountability Integrity Reliability HHS Needs to Continue Its Actions a... |
| Date May 15, 2008 |
Report No. GAO-08-600 |
Title
United States Government Accountability Office GAO
May 2008 Report to Congressional Requesters MOTOR CARRIER SAFETY Improvements to Drug Testing Programs Could Better Identify Illegal Drug Users and Keep Them off the Road GAO-08-600 May 2008 MOTOR CARRIER SAFETY Highlights
Highlights of GAO-08-600, a report to congressional requesters Accountability Integrity Reliability Improvements to Drug Testi... |
| Date April 22, 2008 |
Report No. GAO-08-701T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 11:00 a.m. EDT Tuesday, April 22, 2008 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DRUG SAFETY Preliminary Findings Suggest Recent FDA Initiatives Have Potential, but Do Not Fully Address Weaknesses in Its Foreign Drug Inspection P... |
| Date April 4, 2008 |
Report No. GAO-08-327 |
Title
United States Government Accountability Office GAO
April 2008 Report to Congressional Committees DOD PHARMACY PROGRAM Continued Efforts Needed to Reduce Growth in Spending at Retail Pharmacies GAO-08-327 April 2008 DOD PHARMACY PROGRAM Highlights
Highlights of GAO-08-327, a report to congressional committees Accountability Integrity Reliability Continued Efforts Needed to Reduce Growth in Spending... |
| Date Oct. 31, 2007 |
Report No. GAO-08-15 |
Title
|
| Date May 22, 2007 |
Report No. GAO-07-898T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, May 22, 2007 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PEDIATRIC DRUG RESEARCH The Study and Labeling of Drugs for Pediatric Use under the Best Pharmaceuticals for Children Act
Statement of Marcia Crosse Director, Health Care G... |
| Date May 9, 2007 |
Report No. GAO-07-856T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT May 9, 2007 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives DRUG SAFETY Further Actions Needed to Improve FDA’s Postmarket Decision-making Process
Statement of Marcia Crosse Director, Health Care GAO-07-856T May 9, 2007 DRUG SAFETY Highligh... |
| Date April 30, 2007 |
Report No. GAO-07-554R |
Title
United States Government Accountability Office Washington, DC 20548 April 30, 2007 The Honorable Ike Skelton Chairman The Honorable Duncan Hunter Ranking Member Committee on Armed Services House of Representatives The Honorable Vic Snyder Chairman The Honorable John M. McHugh Ranking Member Subcommittee on Military Personnel Committee on Armed Services House of Representatives Subject: DOD and VA ... |
| Date March 22, 2007 |
Report No. GAO-07-599T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:30 a.m. EDT March 22, 2007 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DRUG SAFETY FDA Needs to Further Address Shortcomings in Its Postmarket Decisionmaking Process
Statement of Marcia Crosse Director, Health Care GAO-07-599T Ma... |
| Date March 22, 2007 |
Report No. GAO-07-557 |
Title
United States Government Accountability Office GAO
March 2007 Report to Congressional Committees PEDIATRIC DRUG RESEARCH Studies Conducted under Best Pharmaceuticals for Children Act GAO-07-557 March 2007 PEDIATRIC DRUG RESEARCH Highlights
Highlights of GAO-07-557, a report to congressional committees Accountability Integrity Reliability Studies Conducted under Best Pharmaceuticals for Children Ac... |
| Date Jan. 11, 2007 |
Report No. GAO-07-358T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Thursday, January 11, 2007 Testimony Before the Committee on Finance, U.S. Senate PRESCRIPTION DRUGS An Overview of Approaches to Negotiate Drug Prices Used by Other Countries and U.S. Private Payers and Federal Programs
Statement of John E. Dicken Director, Health Care GAO-07-358T January 11, 200... |
| Date Aug. 25, 2006 |
Report No. GAO-06-818 |
Title
United States Government Accountability Office GAO
August 2006 Report to the Subcommittee on Transportation, Treasury, the Judiciary, Housing and Urban Development, and Related Agencies, Committee on Appropriations, U.S. Senate ONDCP MEDIA CAMPAIGN Contractor’s National Evaluation Did Not Find That the Youth Anti-Drug Media Campaign Was Effective in Reducing Youth Drug Use GAO-06-818 August 2006... |
| Date March 31, 2006 |
Report No. GAO-06-402 |
Title
United States Government Accountability Office GAO
March 2006 Report to Congressional Requesters DRUG SAFETY Improvement Needed in FDA’s Postmarket Decision-making and Oversight Process GAO-06-402 March 2006 DRUG SAFETY Highlights
Highlights of GAO-06-402, a report to the Chairman, Committee on Finance, United States Senate and the Chairman, Committee on Energy and Commerce, House of Representat... |
| Date Dec. 16, 2005 |
Report No. GAO-06-278R |
Title
United States Government Accountability Office Washington, DC 20548 December 16, 2005 The Honorable Max Baucus Ranking Minority Member Committee on Finance United States Senate Subject: Medicare: Contingency Plans to Address Potential Problems with the Transition of Dual-Eligible Beneficiaries from Medicaid to Medicare Drug Coverage Dear Senator Baucus: The Medicare Prescription Drug, Improvement,... |
| Date Dec. 15, 2005 |
Report No. GAO-06-63 |
Title
United States Government Accountability Office GAO
December 2005 Report to Congressional Committees MEDICARE AND MEDICAID COVERAGE Therapies and Supplies for Inflammatory Bowel Disease GAO-06-63 December 2005 MEDICARE AND MEDICAID COVERAGE Highlights
Highlights of GAO-06-63, a report to congressional committees Accountability Integrity Reliability Therapies and Supplies for Inflammatory Bowel Dise... |
| Date Dec. 13, 2005 |
Report No. GAO-06-175T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Tuesday, December 13, 2005 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives PRESCRIPTION DRUGS Enhanced Efforts and Better Agency Coordination Needed to Address Illegal Importation
Statement of Richard M. Stana, Direc... |
| Date Nov. 18, 2005 |
Report No. GAO-06-139R |
Title
United States Government Accountability Office Washington, DC 20548 November 18, 2005 The Honorable Henry A. Waxman Ranking Minority Member Committee on Government Reform House of Representatives Subject: Medicare: CMS’s Beneficiary Education and Outreach Efforts for the Medicare Prescription Drug Discount Card and Transitional Assistance Program Dear Mr. Waxman: Established by the Medicare Pres... |
| Date Nov. 16, 2005 |
Report No. GAO-06-147R |
Title
United States Government Accountability Office Washington, DC 20548 November 16, 2005 The Honorable Judd Gregg Chairman Committee on the Budget United States Senate The Honorable Russell D. Feingold Ranking Minority Member Subcommittee on African Affairs Committee on Foreign Relations United States Senate The Honorable Tom Coburn Chairman Subcommittee on Federal Financial Management, Government In... |
